Cspc Baike (shandong) Biopharmaceutical Co., Ltd.
Clinical trials sponsored by Cspc Baike (shandong) Biopharmaceutical Co., Ltd., explained in plain language.
-
New hope for stuffy noses: drug targets nasal polyps
Symptom relief Not yet recruitingThis study tests an experimental drug called CM326 in 212 adults with chronic sinusitis and nasal polyps (growths in the nose). The goal is to see if it shrinks polyps and eases congestion better than a placebo. Participants will receive the drug or placebo for 24 weeks, followed…
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 11:47 UTC
-
Healthy volunteers needed to test injection methods for new drug
Knowledge-focused Not yet recruitingThis study tests a new drug called CM326 in healthy adults to see how it behaves in the body when given through different injection devices. About 192 healthy men aged 18 to 55 will receive a single shot, and researchers will measure drug levels and safety. The goal is to compare…
Phase: PHASE1 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC